Shuttle Pharmaceuticals Holdings, Inc.
SEC CIK 1757499 · SHPH) · last insider filing 2026-06-01
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Liriano Angel | Director | filed 2025 - 2025 |
| Pathigoda Arachchige Sachin Eranga | Director | filed 2025 - 2025 |
| Chambers Adam V | Director | filed 2025 - 2025 |
| Richards Steven M | Director | filed 2022 - 2025 |
| Scorsis George | Director | filed 2025 - 2025 |
| Nabyt Oleh | Director | filed 2025 - 2025 |
| Tung Joseph | Director | filed 2025 - 2025 |
| Schafer Joshua | Director | filed 2022 - 2025 |
| Brown Milton | Director | filed 2022 - 2025 |
| Senanayake Chris | Director | filed 2022 - 2024 |
| Jacobs Bette | Director | filed 2022 - 2023 |
| Dritschilo Anatoly | Director · CEO and Chairman | filed 2022 - 2023 |
| Adkins William | Director | filed 2022 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Trasolini Ryan | Co-Chief Executive Officer | filed 2026 - 2026 |
| Liang Yuying | Chief Financial Officer | filed 2026 - 2026 |
| Lorber Timothy J. | Chief Financial Officer | filed 2024 - 2025 |
| Cooper Chris | Interim Co-CEO | filed 2025 - 2025 |
| Jung Mira | Chief Scientific Officer | filed 2022 - 2024 |
| Vander Hoek Michael | Chief Financial Officer | filed 2022 - 2024 |
| Rich Tyvin | Chief Medical Officer | filed 2022 - 2023 |
| Dritschilo Peter | President and COO | filed 2022 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.